Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | ADH1B | P00325 | 2/20 | 0.40 |
| ▸ | ADH1A | P07327 | 2/20 | 0.40 |
| ▸ | ADH7 | P40394 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL27572702 | 0.83 | LMNA (0.48) | LMNAALOX15HSD17B10ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL28352657 | 0.82 | ZDHHC20 (0.60) | PAOXZDHHC20ZDHHC2TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL11378654 | 0.82 | ZDHHC20 (0.60) | PAOXZDHHC20ZDHHC2TSHRALDH1A1 | |
| Fumaric Acid SCHEMBL21145333 | 0.82 | TSHR (0.47) | PAOXTSHRALDH1A1ADH1BADH1A | |
| Fumaric Acid SCHEMBL21145335 | 0.82 | TSHR (0.47) | PAOXTSHRALDH1A1ADH1BADH1A | |
| Acrylic Acid SCHEMBL27551325 | 0.81 | ALOX15 (0.50) | LMNAALOX15HSD17B10ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL18042439 | 0.81 | LMNA (0.67) | LMNAALOX15HSD17B10ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL30785183 | 0.81 | LMNA (0.67) | LMNAALOX15HSD17B10ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL1899595 | 0.81 | — | — | |
| Bicarbonate SCHEMBL28444878 | 0.81 | PAOX (0.54) | PAOXALOX15TSHRALDH1A1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528948-B2 | Amino (meth)acrylates | ALLNEX BELGIUM S.A. (BE) | 2026-01-20 | — | — | US | disclosed |
| US-20230151222-A1 | AMINO (METH)ACRYLATES | ALLNEX BELGIUM S.A. (BE) | 2023-05-18 | — | — | US | disclosed |
| EP-1893657-B1 | LOW EXTRACTABLE RADIATION CURABLE COMPOSITIONS CONTAINING AMINOACRYLATES | ALLNEX Belgium SA (BE) | 2018-08-22 | — | — | EP | disclosed |
| EP-1893657-A2 | LOW EXTRACTABLE RADIATION CURABLE COMPOSITIONS CONTAINING AMINOACRYLATES | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006131259-A2 | LOW EXTRACTABLE RADIATION CURABLE COMPOSITIONS CONTAINING AMINOACRYLATES | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2006-12-14 | — | — | WO | disclosed |
| EP-1731541-A1 | Low extractable radiation curable compositions containing aminoacrylates | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2006-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528948-B2 | Amino (meth)acrylates | MAT2B, MAT1A, MMAB | LMNA 996/4885PAOX 4366/4885ALOX15 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.